Covidence vs Rayyan: Which Screening Tool Wins?

Covidence and Rayyan are the two most widely used screening tools for systematic reviews, but they serve different needs and excel in different areas. Covidence is a comprehensive end-to-end review management platform endorsed by Cochrane, while Rayyan is a focused screening tool with superior AI-assisted relevance prediction and a generous free tier. If cost or data-residency rules out both, our free Rayyan and Covidence alternative runs screening in your browser with no record cap. This comparison covers every feature, pricing detail, and use case to help you choose the right tool for your systematic review.

The short answer: if your institution provides Covidence access, use it for its complete workflow coverage. If you need the best free option or are working with a very large number of records, Rayyan's AI screening is hard to beat. Many experienced teams use both, leveraging Rayyan's screening strengths with Covidence's extraction and reporting capabilities.

Head-to-Head Feature Comparison

Screening: Where Rayyan Wins

Rayyan's core advantage is its active learning AI model. After you screen approximately 50 to 100 records, Rayyan's algorithm begins predicting the relevance of unscreened records based on patterns in your include/exclude decisions. The model improves with every decision, eventually ranking the most likely relevant studies at the top of your screening queue.

This means you encounter relevant studies early in the process, and as you screen further into increasingly irrelevant records, you can apply stopping rules with confidence that you have found most or all relevant studies. Research has shown that Rayyan's AI can reduce the number of records you need to manually screen by 50 to 70 percent while maintaining sensitivity above 95 percent.

Covidence offers basic machine learning prioritization, but it does not provide the real-time active learning feedback loop that makes Rayyan's screening so efficient. For reviews with large numbers of records (5,000+), this difference translates into weeks of saved screening time.

Rayyan's blind review mode is another screening strength. In blind mode, reviewers cannot see each other's decisions until both have completed screening for a given batch. This ensures truly independent assessment, which is methodologically important for reducing bias in the screening process. Covidence also supports independent screening but does not have a dedicated blind mode interface.

Beyond Screening: Where Covidence Wins

Covidence covers the entire systematic review workflow after screening, which is where Rayyan stops. Once you have identified your included studies, Covidence provides:

Data Extraction

Covidence offers customizable systematic review data extraction process forms that support dual extraction with reconciliation. Two reviewers independently extract data from each included study, and Covidence highlights discrepancies for resolution. This eliminates the need for separate spreadsheets and reduces extraction errors.

Quality Assessment

Built-in templates for the most common risk of bias tools let you complete quality assessment within the same platform:

• learn about rob 2 for randomized controlled trials
• learn about robins-i for non-randomized studies
• Newcastle-Ottawa quality assessment guide for observational studies
• Custom templates for any other assessment framework

PRISMA Compliance

Covidence auto-generates a PRISMA flow diagram based on your screening and selection decisions, populating the number of records at each stage. This saves significant time compared to manually creating the flow diagram.

Cochrane Integration

For Cochrane review teams, Covidence's direct RevMan export is a major advantage. Extracted data transfers seamlessly into RevMan Web for our guide to meta-analysis, forest plot generation, and GRADE assessment.

Pricing Comparison (2026)

Pricing verified from the Covidence and Rayyan public pricing pages in July 2026. Covidence offers no student discount; concessions are limited to low- and middle-income countries.

Check your institutional access first. Many university libraries subscribe to Covidence, giving students and faculty full access at no personal cost. Ask your library or check your institution's research tools portal before purchasing.

Want to skip the software learning curve entirely? Our team uses validated workflows with the best screening and analysis tools to deliver completed systematic reviews in 8 to 12 weeks. request your detailed research estimate, or explore our professional systematic review screening support.

Best Use Cases for Each Tool

Choose Covidence When:

• Your institution provides access (most common scenario)
• You are conducting a Cochrane review requiring RevMan integration
• You need data extraction and quality assessment in the same platform
• Your team values an all-in-one workflow over specialized screening features
• Your review has fewer than 3,000 records to screen

Choose Rayyan When:

• You need a free screening tool with no budget for software
• Your review has a large volume of records (5,000+) where AI screening saves weeks
• You want the most advanced AI-assisted screening available
• You are comfortable using a separate tool or spreadsheet for data extraction
• You are working on multiple reviews simultaneously (3 free active reviews)

Use Both When:

• You want Rayyan's AI for initial title-abstract screening (speed) combined with Covidence's structured workflow for full-text screening, extraction, and quality assessment (completeness)
• Your institution has Covidence access but your review has 10,000+ records where Rayyan's AI provides significant screening time savings

Workflow: Using Rayyan and Covidence Together

Many experienced systematic review teams use a combined workflow:

1. Import references into Rayyan for title-abstract screening. Take advantage of AI prediction to accelerate screening
2. Export included studies from Rayyan as RIS or CSV
3. Import into Covidence for full-text screening with PDF management
4. Complete data extraction in Covidence using customizable forms
5. Run quality assessment in Covidence using built-in RoB 2 or ROBINS-I templates
6. Export to RevMan (Cochrane) or to spreadsheet for meta-analysis in R
7. Generate PRISMA diagram from Covidence screening statistics

This hybrid workflow gives you the best of both tools: Rayyan's screening efficiency and Covidence's comprehensive review management.

Alternatives Worth Considering

If neither Covidence nor Rayyan fits your needs, consider these alternatives:

• ASReview (free, open source) for AI-prioritized screening with active learning, particularly strong for very large record sets
• DistillerSR (enterprise) for organizations conducting multiple reviews with advanced AI and regulatory compliance features
• EPPI-Reviewer for mixed-methods reviews combining quantitative and qualitative evidence
• Our 32 free research tools including PRISMA flow chart builder tool, risk of bias chart, free forest plot maker, and our effect size calculator for specific analysis phases

For a comprehensive comparison of all available tools, see our best systematic review software guide.

If neither Covidence nor Rayyan suits your workflow, explore other Covidence alternatives beyond Rayyan for more options.

Both platforms are now integrating machine learning features. For a broader look, see our roundup of AI screening tools that complement traditional software.